BMY-7378

In today's world, BMY-7378 has acquired increasing importance in different areas of society. From politics to technology, through culture and economics, BMY-7378 has become a topic of constant debate and general interest. Its implications and consequences are diverse and its influence is noticeable at all levels, affecting people's lives directly and indirectly. In this article, we will explore the different facets of BMY-7378 and analyze its impact on contemporary society, as well as possible solutions and alternatives to address its challenges.

BMY-7378
Identifiers
  • 8-(2-ethyl)-8-azaspirodecane-7,9-dione
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H31N3O3
Molar mass385.508 g·mol−1
3D model (JSmol)
  • C4CCCC4(CC1=O)CC(=O)N1CCN3CCN(CC3)c2ccccc2OC
  • InChI=1S/C22H31N3O3/c1-28-19-7-3-2-6-18(19)24-13-10-23(11-14-24)12-15-25-20(26)16-22(17-21(25)27)8-4-5-9-22/h2-3,6-7H,4-5,8-17H2,1H3 ☒N
  • Key:AYYCFGDXLUPJAQ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

BMY-7,378 is a 5-HT1A receptor weak partial agonist/antagonist and α1D-adrenergic receptor antagonist.[1]

References

  1. ^ Goetz AS, King HK, Ward SD, True TA, Rimele TJ, Saussy DL (January 1995). "BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors". European Journal of Pharmacology. 272 (2–3): R5–6. doi:10.1016/0014-2999(94)00751-R. PMID 7713154.


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.